Viewing Study NCT02063958


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2025-12-25 @ 10:04 PM
Study NCT ID: NCT02063958
Status: COMPLETED
Last Update Posted: 2018-07-30
First Post: 2014-02-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors
Sponsor: Esanex Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module